Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 47, Issue 4, 2007, Pages 321-325

  Aytan, Hakan ^a   Caliskan, Ahmet C ^a   Demirturk, Fazli ^a   Aytan, Pelin ^b   Koseoglu, Dogan R ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b Cevdet Aykan State Hospital   (Turkey)

Author keywords

Endometriosis; PPAR ; Rat model; Rosiglitazone

Indexed keywords

DRUG VEHICLE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEATH; DRUG EFFECT; ECTOPIC TISSUE; ENDOMETRIOSIS; EPITHELIUM; FEMALE; HISTOPATHOLOGY; LAPAROTOMY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; SCORING SYSTEM; WISTAR ALBINO GLAXO RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; MACROPHAGES; PPAR GAMMA; RATS; RATS, WISTAR; REMISSION INDUCTION; THIAZOLIDINEDIONES;

EID: 34447518775     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2007.00744.x     Document Type: Article

References (36)

1. Garcia-Velasco JA, Arici A, Zreik T, Naftolin F, Mor G. Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: A role in endometriosis. Mol Hum Reprod 1999; 5: 642-650.
2. Lebovic DI, Bentzien F, Chao VA, Garrett EN, Meng YG, Taylor RN. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1β. Mol Hum Reprod 2000; 6: 269-275.
3. Mathur SP. Autoimmunity in endometriosis: Relevance to infertility. Am J Reprod Immunol 2000; 44: 89-95.
4. Ramey JW, Archer DF. Peritoneal fluid: Its relevance to the development of endometriosis. Fertil Steril 1993; 60: 1-14.
5. Oral E, Olive DL, Arici A. The peritoneal environment in endometriosis. Hum Reprod 1996; 2: 385-398.
6. Oral E, Arici A. Peritoneal growth factors and endometriosis. Semin Reprod Endocrinol 1996; 14: 257-267.
7. Kayisli UA, Mahutte NG, Arici A. Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 2002; 47: 213-221.
8. Garcia-Velasco JA, Arici A. Chemokines and human reproduction. Fertil Steril 1999; 71: 983-993.
9. Harada T, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril 2001; 76 (Suppl. 1): 1-10.
10. Koninckx PR, Kennedy SH, Barlow DH. Pathogenesis of endometriosis: The role of peritoneal fluid. Gynecol Obstet Invest 1999; 47: 23-33.
11. Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril 2002; 77: 861-870.
12. Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol 2003; 49: 285-296.
13. Sillem M, Prifti S, Monga B, Arslic T, Runnebaum B. Integrin-mediated adhesion of uterine endometrial cells from endometriosis patients to extracellular matrix proteins is enhanced by tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1). Eur J Obstet Gynecol Reprod Biol 1999; 87: 123-127.
14. Sillem M, Prifti S, Koch A, Neher M, Jauckus J, Runnebaum B. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur J Obstet Gynecol Reprod Biol 2001; 95: 167-174.
15. McLaren J, Prentice A, Charnock-Jones DS et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 1996; 98: 482-489.
16. Akoum A, Lawson C, McColl S, Villeneuve M. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by upregulating IL-1-induced IL-8 expression in vitro. Mol Hum Reprod 2001; 7: 859-866.
17. Demirturk F, Aytan H, Caliskan AC, Aytan P, Koseoglu DR. Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model. J Soc Gynecol Invest 2006; 13: 58-62.
18. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertile Steril 1985; 44: 684-694.
19. Lebovic DI, Kir M, Casey CL. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertil Steril 2004; 82 (Suppl. 3): 1008-1013.
20. Dmowski PW, Braun DP. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 2004; 18: 245-263.
21. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001; 75: 1-10.
22. Sidell N, Han SW, Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis. Ann N Y Acad Sci 2002; 955: 159-173.
23. Rana N, Braun DP, House R Gebel H, Rotman C, Dmowski WP. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril 1996; 65: 925-930.
24. Karck U, Reister F, Schafer W, Zahradnik HP, Breckwoldt M. PGE2 and PGF2-alpha release by human peritoneal macrophages in endometriosis. Prostaglandins 1996; 51: 49-60.
25. Braun DP, Muriana A, Gebel H, Rotman C, Rana N, Dmowski WP. Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertil Steril 1994; 61: 78-84.
26. Steinleiter A, Lambert H, Roy S. Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model: A paradigm for a novel approach to the treatment of endometriosis-associated infertility. Fertil Steril 1991; 56: 975-999.
27. Verghese MW, McConnell TR, Strickland AB, Yarnall DP. Differential regulation of human monocyte-derived TNF-α and IL-1-β by type IV camp phosphodiesterases (cAMP-PDE) inhibitors. J Pharmacol Exp Therap 1995; 272: 1313-1320.
28. Hill JA, Barbieri RL, Anderson DJ. Immunosuppressive effects of danazol in vitro. Fertil Steril 1987; 48: 414-418.
29. Zhao D, Lebovic DI, Taylor RN. Long-term progestin treatment inhibits RANTES (regulated on activation, normal T cell expressed and secreted) gene expression in human endometrial stromal cells. J Clin Endocrinol Metab 2002; 87: 2514-2519.
30. Garzetti GG, Ciavattini A, Provinciali M, Muzzioli M, Di Stefano G, Fabris N. Natural cytotoxicity and GnRH agonist administration in advanced endometriosis: Positive modulation on natural killer activity. Obstet Gynecol 1996; 88: 234-240.
31. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000; 49: 497-505.
32. Yee LD, Sabourin CL, Liu L et al. Peroxisome proliferator-activated receptor gamma activation in human breast cancer. Int J Oncol 1999; 15: 967-973.
33. Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM, Walker CL. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. Cancer Res 2003; 63: 1221-1227.
34. Heaney AP, Fernando M, Melmed S. PPAR-gamma receptor ligands: Novel therapy for pituitary adenomas. J Clin Invest 2003; 111: 1381-1388.
35. Dogan S, Machicao F, Wallwiener D, Haering HU, Diedrich K, Hornung D. Association of peroxisome proliferator-activated receptor gamma 2 Pro-12-Ala polymorphism with endometriosis. Fertil Steril 2004; 81: 1411-1413.
36. Kiyomizu M, Kitawaki J, Obayashi H et al. Association of two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene with adenomyosis, endometriosis, and leiomyomata in Japanese women. J Soc Gynecol Invest 2006; 13: 372-377.